Treace Medical Concepts (TMCI): Company Cash Volume

Official company branding of Treace Medical (TMCI)

The cash level formed by GURU.Markets quotes reflects the financial dynamics of Treace Medical Concepts (TMCI), which develops automated tools for foot correction. The value of 0.04 determines the current status of the liquidity parameter that supports the brand's leadership through Lapiplasty patents. Business resilience is ensured by the recruitment of leading engineers and physicians who implement innovative methods in orthopedics.

Company Cash Funds: Treace Corp (TMCI) for 07/04/2022 - 11/21/2026

Summary analytical data breakdowns for Treace Medical Concepts Inc (TMCI)

- stock quotes and analyst forecast:
Initial company analysis:Treace Corp TMCI
Brand item of Treace Medical Concepts, Inc.

This indicator measures the volume of liquid assets, serving as a gauge of internal financial autonomy and the business's ability to respond swiftly to market challenges. By analyzing the cash position chart, an investor can see the resource base for the expansion of Treace Medical Concepts (TMCI) innovative foot correction systems. Effective management of this capital during the market capture phase confirms the resilience of the business model. Excessive accumulation without investments in growth may signal a decline in return on assets.

Analysis of competing companies

Company Cash Volume BSX|Company Cash Funds EW (Edwards Lifesciences Corporation)|Company Cash Funds ResMed RMD|Company Cash Volume Insulet Corp PODD|ZBH: Company Cash on Hand|Company Cash Balance COO (CooperVision)|ALGN (Align Technology, Inc.) - Company Cash on Hand|Globus Medical, Inc. - Company Cash Balance|TMDX (TransMedics Group Inc) - Company Cash Volume|Company Cash Reserve Alphatec Holdings ATEC|Company Cash Funds CryoLife (AORT)|Enovis Corporation (ENOV) - Company Cash Position|Integra LifeSciences Inc. - Company Cash on Hand|Company Cash Volume Establishment Labs ESTA|Beta Bionics, Inc. - Company Cash Volume|Company Liquid Assets IRADIMED Corp IRMD|Embecta (EMBC) - Company Cash Funds|Company Total Cash Volume TNDM (Tandem Corp)|Company Cash Funds axogeninc.com|Company Cash on Hand SI-BONE, Inc. (SIBN)|Company Cash Volume OFIX|Bioventus Corp - Company Cash and Cash Equivalents|Company Cash Funds orthopediatrics.com KIDS|SRTA: Company Cash and Cash Equivalents|CARL: Company Cash on Hand|rxsight.com - Company Total Cash Amount|CLPT: Company Cash Volume|STXS - Company Liquid Assets|STIM (neurostar.com) - Company Cash Volume|Sight Sciences, Inc (SGHT) - Company Liquid Assets|Company Cash Volume OBIO|Company Liquid Assets Anika Therapeutics Inc.|Company Cash Funds InspireMD, Inc. NSPR|Company Cash Balance ZJYL|VANI - Company Cash Funds|Xtant Medical Holdings, Inc. - Company Total Cash Amount|NeuroOne (NMTC) - Company Cash Funds|Modular Med (MODD) - Company Cash Volume|Company Cash Funds Myomo, Inc|Company Cash on Hand Envoy Medical (COCH)|Company Cash Volume VVOS|NVNO (enVVeno Corp) - Company Cash Balance|Company Cash Volume SINT (Sintx Technologies)|TNON: Company Cash and Cash Equivalents|Lifeward - Company Cash Volume|Company Cash Balance AMIX (Autonomix Medical)|IVF: Company Cash Volume|Company Cash Position Bone Biologics Corporation BBLG|Company Cash on Hand AXNX|BIOLASE, Inc. (BIOL) - Company Liquid Assets|Company Cash Volume DYNT|Company Liquid Assets Paragon 28|Company Cash Volume INVO (INVO Bioscience, Inc.)